Consultations

Search consultations and choose filters to show only the results you want

Filter search results

Topic

Publication date

Department

535 consultations

Equality and Human Rights Consultation - NICE TA - Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase fusion gene

Published 10 November 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Everolimus with Exemestane for Treating Advanced Breast Cancer after Endocrine Therapy

Published 10 November 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE CG 19 - Dental Checks: Intervals between Oral Health Reviews

Published 08 November 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Ticagrelor for secondary prevention of atherothrombotic events after myocardial infarction [ID813]

Published 04 November 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Eribulin for treating locally advanced or metastatic breast cancer after two or more prior chemotherapy regimens (Review of TA250) [ID964]

Published 03 November 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE CG 50 - Acutely ill Adults in Hospital: Recognising and Responding to Deterioration - Section 75 Questionnaire

Published 02 November 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE NG 57 - Physical Health of People in Prison - Section 75 Questionnaire

Published 02 November 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Nivolumab for Treated or Metastatic Renal Cell Carcinoma [ID853]

Published 21 October 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Apremilast for Treating Moderate to Severe Plaque Psoriasis [ID987] (Rapid Review of TA368)

Published 20 October 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Dapagliflozin in Triple Therapy for Treating Type 2 Diabetes

Published 07 October 2016ClosedDepartment of Health

Review of the fees charged and the frequency of inspections undertaken by RQIA

Published 07 October 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Certolizumab Pegol for Treating Rheumatoid Arthritis after Inadequate Response to a TNF Inhibitor

Published 22 September 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE NG 56 - Multimorbidity: Clinical Assessment and Management

Published 21 September 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE NG 55 - Harmful Sexual Behaviour among Children and Young People

Published 20 September 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE NG 54 - Mental Health Problems in People with Learning Disabilities: Prevention, Assessment and Management

Published 14 September 2016ClosedDepartment of Health

Protect Life 2 - A Strategy for Suicide Prevention in the north of Ireland

Published 09 September 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Elbasvir-grazoprevir for treating chronic hepatitis C

Published 09 September 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors

Published 08 September 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma

Published 05 September 2016ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Radium-223 dichloride for treating metastatic hormone relapsed prostate cancer with bone metastases (Review of TA376)

Published 02 September 2016ClosedDepartment of Health

Pages

Back to top